Tearsheet

MSP Recovery (MSPR)


Market Price (12/22/2025): $0.199 | Market Cap: $0.3 Mil
Sector: Health Care | Industry: Health Care Technology

MSP Recovery (MSPR)


Market Price (12/22/2025): $0.199
Market Cap: $0.3 Mil
Sector: Health Care
Industry: Health Care Technology

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine. Themes include Health Data Analytics, and AI in Healthcare Management.
Weak multi-year price returns
2Y Excs Rtn is -143%, 3Y Excs Rtn is -169%
Penny stock
Mkt Price is 0.2
1   Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -502 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -5116%
2   Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 351930%
3   Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -8.6%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -17%, Rev Chg QQuarterly Revenue Change % is -95%
4   Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -177%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -182%
5   Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 191%
6   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -284405%
7   High stock price volatility
Vol 12M is 704%
8   Significant short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 37%
9   Key risks
MSPR key risks include [1] substantial doubt about its ability to continue as a going concern and a Nasdaq delisting threat, Show more.
0 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine. Themes include Health Data Analytics, and AI in Healthcare Management.
1 Weak multi-year price returns
2Y Excs Rtn is -143%, 3Y Excs Rtn is -169%
2 Penny stock
Mkt Price is 0.2
3 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -502 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -5116%
4 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 351930%
5 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -8.6%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -17%, Rev Chg QQuarterly Revenue Change % is -95%
6 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -177%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -182%
7 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 191%
8 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -284405%
9 High stock price volatility
Vol 12M is 704%
10 Significant short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 37%
11 Key risks
MSPR key risks include [1] substantial doubt about its ability to continue as a going concern and a Nasdaq delisting threat, Show more.

Valuation, Metrics & Events

MSPR Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Following are key points explaining the approximate -55.5% movement in MSP Recovery (MSPR) stock. 1. Nasdaq Delisting Threats and Non-Compliance

MSP Recovery faced severe delisting threats from Nasdaq in late 2025. On October 22, 2025, the company received a Staff Delisting Determination from Nasdaq due to non-compliance with minimum stockholders' equity and other financial standards, leading to the suspension of trading from the Nasdaq Capital Market effective October 31, 2025. Additionally, on November 28, 2025, MSP Recovery was notified of non-compliance with the minimum bid price requirement, further jeopardizing its Nasdaq listing. Earlier, on May 1, 2025, MSP Recovery was notified of non-compliance with the minimum stockholders' equity requirement, with a reported deficit of ($128,409,000) as of December 31, 2024. 2. Significant Financial Losses and Negative Shareholder Equity

The company reported substantial financial instability, with a net loss of approximately $1.56 billion for the fiscal year ended December 31, 2024, and an operating loss of $1.274 billion for the same period. The company's total shareholder equity was deeply negative, recorded at $-844.4 million, reflecting a precarious financial position. This significant deficit in stockholders' equity was a primary reason for the Nasdaq non-compliance.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
MSPR Return0%42%-98%
Peers Return
S&P 500 Return16%27%-19%24%23%16%112%

Monthly Win Rates [3]
MSPR Win Rate43%0%8%42% 
Peers Win Rate45% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
MSPR Max Drawdown0%0%-99% 
Peers Max Drawdown 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: CTEV, UNH, CNDT, MDRX, HQY.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/19/2025 (YTD)

How Low Can It Go

Unique KeyEventMSPRS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-80.6%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven416.3%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days

Compare to OMCL, BEAT, CARL, HTFL, VEEV


In The Past

MSP Recovery's stock fell -80.6% during the 2022 Inflation Shock from a high on 5/24/2022. A -80.6% loss requires a 416.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About MSP Recovery (MSPR)

Better Bets than MSP Recovery (MSPR)

Trade Ideas

Select past ideas related to MSPR. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
17.4%17.4%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-6.7%-6.7%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
10.9%10.9%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
2.7%2.7%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
11.4%11.4%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
17.4%17.4%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-6.7%-6.7%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
10.9%10.9%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
2.7%2.7%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
11.4%11.4%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for MSP Recovery

Peers to compare with:

Financials

MSPRCTEVUNHCNDTMDRXHQYMedian
NameMSP Reco.Claritev UnitedHe.Conduent Veradigm HealthEq. 
Mkt Price0.2041.02327.422.064.8395.5022.92
Mkt Cap0.00.7296.60.30.58.20.6
Rev LTM10951435,1593,0725881,2911,121
Op Inc LTM-5025026,357-85-2029915
FCF LTM-18-11317,372-1308336333
FCF 3Y Avg-31218,968-93-79126-14
CFO LTM-171820,958-7111641567
CFO 3Y Avg-2811922,443-7-2232656

Growth & Margins

MSPRCTEVUNHCNDTMDRXHQYMedian
NameMSP Reco.Claritev UnitedHe.Conduent Veradigm HealthEq. 
Rev Chg LTM-8.6%0.9%10.5%-12.5%1.8%12.2%1.4%
Rev Chg 3Y Avg-16.6%-5.5%11.4%-7.7%-20.1%15.8%-6.6%
Rev Chg Q-94.6%6.7%12.2%-5.0%-9.7%7.2%0.9%
QoQ Delta Rev Chg LTM-26.1%1.7%2.9%-1.3%-2.5%1.7%0.2%
Op Mgn LTM-5,116.2%5.2%6.1%-2.8%-3.3%23.2%1.2%
Op Mgn 3Y Avg-5,574.9%12.5%7.7%0.2%4.4%17.1%6.1%
QoQ Delta Op Mgn LTM-1,290.4%-1.5%-1.2%-0.2%-13.3%1.6%-1.4%
CFO/Rev LTM-176.6%1.9%4.8%-2.3%19.7%32.1%3.3%
CFO/Rev 3Y Avg-305.4%12.6%5.8%-0.3%-4.1%28.2%2.7%
FCF/Rev LTM-181.9%-11.8%4.0%-4.2%14.2%28.1%-0.1%
FCF/Rev 3Y Avg-328.7%0.2%4.9%-2.8%-14.2%10.7%-1.3%

Valuation

MSPRCTEVUNHCNDTMDRXHQYMedian
NameMSP Reco.Claritev UnitedHe.Conduent Veradigm HealthEq. 
Mkt Cap0.00.7296.60.30.58.20.6
P/S0.00.70.70.10.96.40.7
P/EBIT-0.0-8.611.3-2.0-9.126.9-1.0
P/E-0.0-2.016.9-2.2-6.042.8-1.0
P/CFO-0.038.414.2-4.64.519.89.3
Total Yield-284,401.2%-50.5%8.6%-46.1%-16.6%2.3%-31.3%
Dividend Yield0.0%0.0%2.6%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg-17,712.5%-4.5%-16.8%-1.4%1.7%-1.4%
D/E3,526.56.90.32.70.40.11.6
Net D/E3,519.36.80.22.0-0.40.11.1

Returns

MSPRCTEVUNHCNDTMDRXHQYMedian
NameMSP Reco.Claritev UnitedHe.Conduent Veradigm HealthEq. 
1M Rtn-51.3%-12.9%3.0%10.8%-0.5%-6.3%-3.4%
3M Rtn-86.5%-20.7%-2.1%-27.5%3.5%1.9%-11.4%
6M Rtn-97.7%2.6%9.8%-23.1%7.2%-5.7%-1.6%
12M Rtn-98.4%--32.9%-53.3%-49.2%0.6%-49.2%
3Y Rtn-97.9%--34.4%-49.6%-73.2%57.0%-49.6%
1M Excs Rtn-58.4%-14.7%3.7%7.3%-1.3%-10.7%-6.0%
3M Excs Rtn-88.0%-22.5%-5.5%-30.6%1.7%-2.6%-14.0%
6M Excs Rtn-111.1%-14.6%-3.1%-33.6%-6.0%-19.1%-16.8%
12M Excs Rtn-111.5%--43.9%-65.3%-62.2%-8.1%-62.2%
3Y Excs Rtn-168.8%--106.8%-120.1%-144.9%-19.6%-120.1%

Financials

Segment Financials

Revenue by Segment

$ Mil2024202320222021
Single Segment8   
Claims recovery income 500
Claims recovery service income 191414
Total8231514


Net Income by Segment
$ Mil2024202320222021
Single Segment-835   
Total-835   


Price Behavior

Short Interest

Short Interest: As Of Date11282025
Short Interest: Shares Quantity473,363
Short Interest: % Change Since 11152025-81.7%
Average Daily Volume5,295,705
Days-to-Cover Short Interest1
Basic Shares Quantity1,264,441
Short % of Basic Shares37.4%

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/9/2022-0.8%-11.1%-6.8%
8/11/2022-11.7%15.4%-6.8%
SUMMARY STATS   
# Positive010
# Negative212
Median Positive 15.4% 
Median Negative-6.3%-11.1%-6.8%
Max Positive 15.4% 
Max Negative-11.7%-11.1%-6.8%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251119202510-Q 9/30/2025
6302025814202510-Q 6/30/2025
3312025515202510-Q 3/31/2025
12312024416202510-K 12/31/2024
93020241114202410-Q 9/30/2024
6302024814202410-Q 6/30/2024
3312024515202410-Q 3/31/2024
12312023415202410-K 12/31/2023
93020231114202310-Q 9/30/2023
6302023831202310-Q 6/30/2023
3312023817202310-Q 3/31/2023
12312022727202310-K 12/31/2022
93020221110202210-Q 9/30/2022
6302022812202210-Q 6/30/2022
123120215032022424B3 12/31/2021